Xbiotech Inc (XBIT)

Dec 20, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024

Dec 19, 2024

(XBIT) Proactive Strategies - Stock Traders Daily

Dec 19, 2024

Dec 16, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 16, 2024

Dec 11, 2024

XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World

Dec 11, 2024

Dec 08, 2024

(XBIT) Investment Analysis and Advice - Stock Traders Daily

Dec 08, 2024

Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 30, 2024

Nov 28, 2024

Trend Tracker for (XBIT) - Stock Traders Daily

Nov 28, 2024

Nov 25, 2024

Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 25, 2024

Nov 19, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat

Nov 19, 2024

Nov 19, 2024

Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR

Nov 19, 2024

Nov 17, 2024

How To Trade (XBIT) - Stock Traders Daily

Nov 17, 2024

Nov 14, 2024

XBiotech: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024

Nov 13, 2024

Transforming lives for those battling cancer with the speed & precision of AIRakovina Therapeutics (TSXV: RKV) | GCFF - NAI 500

Nov 13, 2024

Nov 08, 2024

XBiotech (NASDAQ:XBIT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat

Nov 08, 2024

Nov 07, 2024

XBiotech Inc.'s (NASDAQ:XBIT) 12% gain last week benefited both individual investors who own 49% as well as insiders - Simply Wall St

Nov 07, 2024

Nov 06, 2024

(XBIT) Technical Data - Stock Traders Daily

Nov 06, 2024

Oct 31, 2024

XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Oct 31, 2024

Oct 27, 2024

(XBIT) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 27, 2024

Oct 24, 2024

Desmoplastic Small Round Cell Tumor Treatment Market Overall - openPR

Oct 24, 2024

Oct 23, 2024

XBiotech (NASDAQ:XBIT) Stock Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat

Oct 23, 2024

Oct 16, 2024

How the (XBIT) price action is used to our Advantage - Stock Traders Daily

Oct 16, 2024

Oct 14, 2024

Enerflex Ltd. (NYSE:EFXT) Stake Increased by The Manufacturers Life Insurance Company - Defense World

Oct 14, 2024

Oct 14, 2024

Alopecia Areata Market Analysis, Size, Market Report 2024-2033 - WhaTech

Oct 14, 2024

Oct 04, 2024

76,460 Shares in XBiotech Inc. (NASDAQ:XBIT) Acquired by American Century Companies Inc. - Defense World

Oct 04, 2024

Oct 04, 2024

American Century Companies Inc. Acquires Shares of 76,460 XBiotech Inc. (NASDAQ:XBIT) - MarketBeat

Oct 04, 2024

Oct 01, 2024

Cancer Antigen Market Size Is Booming Worldwide with Share, Size, Top Key Players - Talented India

Oct 01, 2024

Oct 01, 2024

Rhumbline Advisers Has $103,000 Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Oct 01, 2024

Sep 28, 2024

Rhumbline Advisers Has $335,000 Stock Position in The First of Long Island Co. (NASDAQ:FLIC) - Defense World

Sep 28, 2024

Sep 25, 2024

Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Sep 25, 2024

Sep 22, 2024

XBiotech (NASDAQ:XBIT) vs. Harmony Biosciences (NASDAQ:HRMY) Financial Contrast - Defense World

Sep 22, 2024

Sep 21, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World

Sep 21, 2024

Sep 21, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average of $6.63 - MarketBeat

Sep 21, 2024

Sep 14, 2024

Objective long/short (XBIT) Report - Stock Traders Daily

Sep 14, 2024

Sep 13, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $6.47 - MarketBeat

Sep 13, 2024

Sep 13, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.47 - Defense World

Sep 13, 2024

Aug 30, 2024

Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load? - Simply Wall St

Aug 30, 2024

Aug 29, 2024

Hidradenitis Suppurativa Market Demand, Share, Size, Trends, Forecast To 2033 - WhaTech

Aug 29, 2024

Aug 23, 2024

Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.

Aug 23, 2024

Aug 17, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Holdings Increased by Vanguard Group Inc. - Defense World

Aug 17, 2024

Aug 14, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.22 - MarketBeat

Aug 14, 2024

Aug 14, 2024

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22 - Defense World

Aug 14, 2024

Aug 13, 2024

XBiotech: Q2 Earnings Snapshot - CT Insider

Aug 13, 2024

Aug 13, 2024

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024

Aug 06, 2024

(XBIT) Trading Signals - Stock Traders Daily

Aug 06, 2024

Aug 03, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35 - Defense World

Aug 03, 2024

Aug 03, 2024

XBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35% - Yahoo Finance

Aug 03, 2024

Aug 03, 2024

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving Average of $6.35 - MarketBeat

Aug 03, 2024

Jul 27, 2024

(XBIT) Investment Analysis - Stock Traders Daily

Jul 27, 2024

Jul 26, 2024

XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - MarketBeat

Jul 26, 2024